Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -27.42%4.75B | -50.40%2.66B | -62.41%1.59B | -6.58%7.3B | 9.08%6.55B | 4.20%5.36B | 43.78%4.22B | -27.13%7.81B | -8.11%6B | -3.46%5.15B |
| Operating revenue | -27.42%4.75B | -50.40%2.66B | -62.41%1.59B | -6.58%7.3B | 9.08%6.55B | 4.20%5.36B | 43.78%4.22B | -27.13%7.81B | -8.11%6B | -3.46%5.15B |
| Other operating revenue | ---- | 28.78%61.87M | ---- | 28.97%126.14M | ---- | 50.96%48.04M | ---- | 48.95%97.8M | ---- | 5.42%31.82M |
| Total operating cost | -18.11%5.45B | -39.07%3.12B | -53.81%1.81B | -7.52%7.56B | 8.24%6.65B | -1.41%5.13B | 34.94%3.91B | -21.78%8.18B | -6.80%6.15B | -2.14%5.2B |
| Operating cost | -23.24%4.24B | -46.09%2.37B | -58.63%1.44B | -11.58%6B | 5.85%5.53B | -4.05%4.39B | 34.32%3.49B | -24.96%6.79B | -5.51%5.22B | 0.07%4.57B |
| Operating tax surcharges | -20.00%95.76M | -32.31%64.4M | -57.40%31.97M | 74.19%157.45M | 101.51%119.71M | 117.44%95.14M | 259.71%75.05M | 90.37%90.39M | -7.36%59.4M | -11.41%43.76M |
| Operating expense | -1.91%257.27M | -4.63%140.63M | -34.36%57.57M | -7.70%353.95M | 6.15%262.27M | -11.13%147.46M | 35.60%87.71M | 8.27%383.46M | 4.82%247.08M | 5.01%165.93M |
| Administration expense | 0.56%246.3M | -1.03%150.25M | 10.55%75.82M | 3.60%400.21M | 2.80%244.92M | -3.59%151.82M | -11.94%68.58M | -8.21%386.29M | -20.32%238.26M | -20.73%157.48M |
| Financial expense | 21.82%573.25M | 17.70%379.94M | 2.17%190.56M | 22.84%605.43M | 32.01%470.56M | 32.10%322.8M | 38.31%186.51M | -11.19%492.87M | -20.21%356.46M | -24.28%244.37M |
| -Interest expense (Financial expense) | ---- | ---- | ---- | 21.68%666.21M | ---- | ---- | ---- | -10.96%547.52M | ---- | ---- |
| -Interest Income (Financial expense) | ---- | ---- | ---- | -3.96%-58.76M | ---- | ---- | ---- | 2.00%-56.52M | ---- | ---- |
| Research and development | 17.49%32.95M | 8.67%22.21M | 4.06%8.84M | 20.81%40.02M | 21.77%28.05M | 41.58%20.43M | 47.22%8.49M | 24.62%33.13M | 1.83%23.03M | 0.48%14.43M |
| Credit Impairment Loss | 56.70%-11.74M | 17.37%1.32M | -54.51%-6.07M | -18.03%-30.08M | -43.85%-27.13M | 109.58%1.13M | 55.54%-3.93M | 57.04%-25.48M | 20.47%-18.86M | 0.25%-11.76M |
| Asset Impairment Loss | 57.12%-158.07M | 271.12%2.07M | ---- | -606.55%-580.04M | -34,919.92%-368.62M | -14,049.78%-1.21M | 100.12%1.74K | -78.69%-82.09M | 116.55%1.06M | -99.80%8.69K |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- |
| Other net revenue | 740.84%586.69M | 11.30%339.23M | -47.89%98.59M | -100.63%-3.87M | -116.81%-91.55M | -27.57%304.8M | -6.57%189.19M | 41.47%614.87M | 9.87%544.66M | 0.48%420.8M |
| Fair value change income | -51.48%24.34M | -92.26%2.16M | -83.28%5.08M | 6.92%124.53M | 70.57%50.16M | -12.61%27.83M | 21.41%30.36M | 23.81%116.48M | -46.17%29.41M | -51.05%31.85M |
| Invest income | 278.51%709.34M | 48.38%316.04M | -13.71%95.99M | -36.13%313.81M | -60.02%187.4M | -45.72%212.99M | -39.56%111.24M | 80.17%491.3M | 48.08%468.74M | 75.90%392.37M |
| -Including: Investment income associates | ---- | ---- | ---- | -30.37%281.54M | ---- | ---- | ---- | 188.20%404.35M | ---- | ---- |
| Asset deal income | 94.84%-43.41K | 94.70%-44.56K | ---- | -100.45%-223.63K | -101.61%-841.36K | -1,502.30%-841.36K | --22.62K | -60.84%49.22M | -58.30%52.29M | -100.04%-52.51K |
| Other revenue | -66.11%22.87M | -72.75%17.68M | -93.02%3.6M | 156.91%168.12M | 461.62%67.47M | 673.80%64.9M | 1,301.61%51.49M | 37.97%65.44M | -58.91%12.01M | -33.21%8.39M |
| Adjusted Items effecting operating profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | --0.01 |
| Operating profit | 44.32%-110.28M | -123.23%-125.34M | -124.85%-123M | -204.62%-264.59M | -149.52%-198.06M | 47.53%539.6M | 109.16%495.01M | -64.17%252.9M | -7.51%399.94M | -15.79%365.76M |
| Add:Non operating Income | -50.04%304.76M | 3,641.21%302.71M | 12,271.04%334.72M | 2,152.07%619.32M | 2,656.18%609.96M | -61.37%8.09M | -85.50%2.71M | -58.42%27.5M | -60.70%22.13M | -52.30%20.95M |
| Less:Non operating expense | 211.32%10.48M | -77.78%327.93K | -95.44%45.13K | -22.51%6.77M | 186.81%3.37M | 63.23%1.48M | 1,488.60%988.9K | 10.79%8.73M | -59.83%1.17M | -42.26%904.28K |
| Total profit | -54.96%184M | -67.59%177.05M | -57.39%211.67M | 28.09%347.97M | -2.94%408.54M | 41.58%546.21M | 94.60%496.73M | -64.44%271.67M | -13.36%420.9M | -19.07%385.8M |
| Less:Income tax cost | -71.39%38.04M | -103.47%-5.06M | -90.32%13.21M | 132.34%217.05M | 105.19%132.98M | 107.80%145.73M | 77.48%136.53M | -63.71%93.42M | -69.45%64.81M | -66.64%70.13M |
| Net profit | -47.03%145.96M | -54.53%182.11M | -44.90%198.46M | -26.55%130.91M | -22.62%275.55M | 26.87%400.48M | 101.98%360.19M | -64.82%178.25M | 30.11%356.09M | 18.47%315.67M |
| Net profit from continuing operation | -47.03%145.96M | -54.53%182.11M | -44.90%198.46M | -26.55%130.91M | -22.62%275.55M | 26.87%400.48M | 101.98%360.19M | -64.82%178.25M | 30.11%356.09M | 18.47%315.67M |
| Less:Minority Profit | -443.68%-132.54M | -97.46%6.54M | -79.26%51.58M | 101.26%299.23K | -53.65%38.56M | 203.93%257.95M | 225.26%248.66M | -112.04%-23.82M | 5.28%83.21M | -23.36%84.87M |
| Net profit of parent company owners | 17.52%278.5M | 23.17%175.57M | 31.68%146.88M | -35.36%130.62M | -13.15%236.99M | -38.24%142.54M | 9.47%111.54M | -34.54%202.07M | 40.19%272.88M | 48.21%230.8M |
| Earning per share | ||||||||||
| Basic earning per share | 50.00%0.18 | 57.14%0.11 | 42.86%0.1 | -103.43%-0.003 | -29.41%0.12 | -53.33%0.07 | 16.67%0.07 | -45.38%0.0874 | --0.17 | 7.14%0.15 |
| Diluted earning per share | 50.00%0.18 | 57.14%0.11 | 42.86%0.1 | -103.43%-0.003 | -29.41%0.12 | -53.33%0.07 | 16.67%0.07 | -45.38%0.0874 | --0.17 | 7.14%0.15 |
| Other composite income | -33.78%15.86M | -237.87%-35.87M | -3,066.09%-39.58M | 53.27%67.05M | -61.16%23.95M | -116.79%-10.62M | -98.10%1.33M | 141.43%43.75M | 271.05%61.66M | 2,280.73%63.25M |
| Other composite income of parent company owners | -19.19%19.36M | -204.96%-32.38M | -3,066.09%-39.58M | 53.06%67.05M | -61.16%23.95M | -116.79%-10.62M | -98.10%1.33M | 141.59%43.81M | 271.05%61.66M | 2,280.73%63.25M |
| Other composite income of minority owners | ---3.49M | ---3.49M | ---- | 94.77%-3.19K | ---- | ---- | ---- | 75.80%-61.06K | ---- | ---- |
| Total composite income | -45.97%161.82M | -62.49%146.24M | -56.05%158.88M | -10.82%197.96M | -28.31%299.5M | 2.89%389.87M | 45.35%361.53M | -44.64%221.99M | 75.80%417.75M | 43.77%378.92M |
| Total composite income of parent company owners | 14.15%297.86M | 8.54%143.19M | -4.94%107.3M | -19.61%197.67M | -22.00%260.94M | -55.14%131.92M | -34.48%112.87M | 20.90%245.88M | 110.94%334.54M | 92.41%294.05M |
| Total composite income of minority owners | -452.74%-136.03M | -98.82%3.05M | -79.26%51.58M | 101.24%296.04K | -53.65%38.56M | 203.93%257.95M | 225.26%248.66M | -112.08%-23.88M | 5.28%83.21M | -23.36%84.87M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Zhonglian Accounting Firm (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.